Peptides
Aminos
Capsules
Supplies
Specialty
Pump Exceed Research Guide: Pre-Workout Pump Blend, v2 & Max v3 — Urea Cycle Amino Acids, NO Synthesis & Fat Oxidation
Exceed Enhancement’s Pump Exceed line is a series of injectable amino acid and metabolic compound formulations designed for research into nitric oxide (NO) production, urea cycle dynamics, mitochondrial fat oxidation, and vascular biology. The product line includes Pump Exceed v2, Pump Exceed Max v3, and the Pre-Workout Pump Blend, each delivering combinations of urea-cycle amino acids, carnitine derivatives, and lipotropic compounds in sterile injectable preparations. This guide covers the science behind each formulation’s components and their research relevance. All content is for informational and scientific reference only.
Pre-Workout Pump Blend
Formulation
Each ml contains:
- L-Ornithine, 100 mg/ml
- L-Arginine, 100 mg/ml
- L-Citrulline, 100 mg/ml
Total amino acid concentration: 300 mg/ml
The NO Precursor Triad: Arginine–Citrulline–Ornithine
These three amino acids form the core of the urea cycle, the hepatic pathway that converts toxic ammonia to urea, and are central to nitric oxide (NO) biosynthesis through their interconnected metabolic relationships:
L-Arginine is the direct substrate for nitric oxide synthase (NOS) enzymes, endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS), which convert arginine to NO and citrulline. NO produced by eNOS in vascular endothelium activates soluble guanylyl cyclase (sGC) in smooth muscle cells, generating cGMP and driving vasodilation. This is the central mechanism of exercise-induced “pump”, increased blood flow and nutrient delivery to working muscle. L-arginine is also a substrate for arginase (producing ornithine + urea) and is involved in polyamine synthesis and creatine biosynthesis.
L-Citrulline is produced endogenously as a byproduct of NO synthesis. In the urea cycle, citrulline is converted back to arginine via argininosuccinate synthase and argininosuccinate lyase, effectively recycling the arginine pool and sustaining NO production longer than arginine supplementation alone. Research has consistently shown that L-citrulline raises plasma arginine levels more effectively than equivalent doses of L-arginine (due to citrulline escaping first-pass intestinal and hepatic arginase metabolism), though in an injectable context this advantage is less pronounced. Citrulline also directly reduces plasma ammonia during exercise, delaying fatigue in endurance models.
L-Ornithine is the urea cycle intermediate formed when arginase cleaves arginine. Ornithine is converted to citrulline in mitochondria by ornithine transcarbamylase (OTC), linking the urea and NO cycles. Ornithine supplementation has demonstrated ammonia-lowering effects in exercising subjects, reducing exercise-induced hyperammonemia and associated central fatigue. Ornithine also serves as a precursor to polyamines (putrescine, spermidine, spermine), essential regulators of cell growth, proliferation, and tissue repair.
Research Applications
- Vascular biology: NO-mediated vasodilation, endothelial function, blood pressure regulation research
- Exercise physiology: Ammonia clearance, fatigue delay, muscle perfusion, oxygen delivery during exercise models
- Urea cycle disorders: OTC deficiency and related enzyme deficiency models where ornithine and citrulline supplementation bypasses defective urea cycle steps
- Polyamine research: Cell proliferation, tissue growth, and wound healing contexts where ornithine-derived polyamine biosynthesis is relevant
Pump Exceed v2
Formulation
Each ml contains:
- L-Carnitine, 200 mg/ml
- L-Citrulline, 100 mg/ml
- L-Ornithine, 100 mg/ml
- L-Arginine, 100 mg/ml
Added Dimension: L-Carnitine Integration
Pump Exceed v2 builds on the Pre-Workout Pump Blend by adding L-Carnitine at 200 mg/ml, integrating mitochondrial fatty acid transport into the NO/urea cycle amino acid framework. This combination is scientifically meaningful beyond simply adding carnitine to an arginine blend:
NO and fat oxidation synergy: Nitric oxide produced via the arginine/citrulline/ornithine triad increases muscle blood flow and oxygen delivery, creating a metabolic environment where mitochondrial fatty acid oxidation (supported by carnitine-mediated LCFA transport) can proceed at higher rates. Research in exercise metabolism has explored whether combined NO-pathway support and carnitine sufficiency produces additive effects on substrate utilization and work capacity compared to either intervention alone.
Carnitine and arginine metabolism: Arginine is a substrate for creatine biosynthesis, and carnitine synthesis itself requires lysine and methionine, but arginine indirectly supports carnitine metabolism by maintaining nitrogen balance. The combination also supports ammonia clearance through both the urea cycle (ornithine/arginine) and carnitine-mediated mitochondrial function.
Body composition research: The combination of enhanced lipolysis (via NO-increased blood flow to adipose tissue) and increased beta-oxidation capacity (via carnitine) makes Pump Exceed v2 relevant to research examining multi-pathway approaches to fat mobilization and oxidation in exercise and metabolic disease models.
Pump Exceed Max v3
Pump Exceed Max v3 is an advanced extension of the v2 formulation that incorporates additional carnitine species alongside the urea-cycle amino acid base and MIC (Methionine-Inositol-Choline) lipotropic complex. This formulation targets a broader metabolic coverage, adding hepatic lipotropic support (MIC complex) and multi-form carnitine activity to the NO and fat oxidation mechanisms of v2. The MIC components support hepatic phospholipid synthesis and fat export (choline), insulin-pathway signaling (inositol), and SAM-mediated methylation reactions (methionine), providing systemic metabolic support for research into comprehensive lipid metabolism and body composition contexts.
Comparative Overview
| Product | Core Components | Primary Research Focus |
|---|---|---|
| Pre-Workout Pump Blend | Arg + Cit + Orn (100 mg each/ml) | NO synthesis, vasodilation, ammonia clearance, urea cycle |
| Pump Exceed v2 | Carnitine 200 + Cit + Orn + Arg (100 mg each/ml) | NO + mitochondrial fat oxidation, body composition |
| Pump Exceed Max v3 | v2 base + MIC complex + additional carnitine species | Comprehensive lipid metabolism, hepatic support, multi-pathway fat oxidation |
Research and Storage Considerations
All Pump Exceed preparations are sterile injectable amino acid solutions. Storage at 2–8°C is recommended; protect from light and avoid freezing. As injectable amino acid preparations, pH stability is critical, formulations should be buffered to physiological pH (7.0–7.4) to ensure comfort and stability. Quality verification should confirm amino acid identity and concentration by HPLC amino acid analysis, osmolality, sterility, and endotoxin testing from the manufacturing source.
Disclaimer
Pump Exceed formulations are sold strictly for in vitro and preclinical research purposes. They are not approved drug products and are not intended for human therapeutic use. This content is for educational and scientific informational purposes only and does not constitute medical advice.
References
- Pérez-Guisado J, Jakeman PM. (2010). Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. Journal of Strength and Conditioning Research, 24(5), 1215–1222.
- Sureda A, Pons A. (2012). Arginine and citrulline supplementation in sports and exercise. Subcellular Biochemistry, 59, 103–123.
- Sugino T, et al. (2008). L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutrition Research, 28(11), 738–743.
- Broad EM, et al. (2008). Effects of four weeks L-carnitine L-tartrate ingestion on substrate utilization during prolonged exercise. International Journal of Sport Nutrition and Exercise Metabolism, 18(6), 567–584.
- Rajapakse NW, Mattson DL. (2009). Role of L-arginine in nitric oxide production in health and hypertension. Clinical and Experimental Pharmacology and Physiology, 36(3), 249–255.
Do you have a dosing protocol available? Does this require reconstitution?